India to Philippines: Dapagliflozin Export Trade Route
India has recorded 40 verified shipments of Dapagliflozin exported to Philippines, representing a combined trade value of $2.4M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $59.4K USD. The leading Indian exporter is INVENTIA HEALTHCARE LIMITED, which accounts for 35% of total export value with 11 shipments worth $822.4K USD. On the buying side, UNILAB, INC. is the largest importer in Philippines with $581.8K USD in purchases. The top 3 suppliers — INVENTIA HEALTHCARE LIMITED, EXEMED PHARMACEUTICALS, MICRO LABS LIMITED — together control 87% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Philippines Dapagliflozin corridor is one of India's established pharmaceutical export routes, with 40 shipments documented worth a combined $2.4M USD. The route is dominated by INVENTIA HEALTHCARE LIMITED, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's dapagliflozin manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $59.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with dapagliflozin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #8 among India's top dapagliflozin export destinations globally.
On the import side, key buyers of Indian dapagliflozin in Philippines include UNILAB, INC., BROWN AND BURK PHILIPPINES INC, AMB HK ENTERPRISES INC and 13 others. UNILAB, INC. is the single largest importer with 4 shipments valued at $581.8K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ3
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#8
- Annual growth+26.8%
- Demand growth+24.4%
- Regulatory ease75/100
Top 10 Indian Dapagliflozin Exporters to Philippines
Showing top 10 of 9 Indian suppliers exporting Dapagliflozin to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INVENTIA HEALTHCARE LIMITED Avg $74.8K per shipment | 11 | $822.4K | 34.6% |
| 2 | EXEMED PHARMACEUTICALS Avg $109.6K per shipment | 7 | $766.9K | 32.3% |
| 3 | MICRO LABS LIMITED Avg $44.4K per shipment | 11 | $488.5K | 20.6% |
| 4 | BAROQUE PHARMACEUTICALS PVT LTD Avg $64.8K per shipment | 3 | $194.4K | 8.2% |
| 5 | Sasha Life Healthcare Avg $22.4K per shipment | 3 | $67.1K | 2.8% |
| 6 | DEEPA INTERNATIONAL Avg $25.4K per shipment | 1 | $25.4K | 1.1% |
| 7 | STALLION LABORATORIES PVT LTD Avg $7.3K per shipment | 1 | $7.3K | 0.3% |
| 8 | SAIN MEDICAMENTS PRIVATE LIMITED Avg $2.6K per shipment | 1 | $2.6K | 0.1% |
| 9 | MITOGENE TECHNOLOGIES PRIVATE LIMITED Avg $87 per shipment | 2 | $175 | 0.0% |
This table shows the top 10 of 9 Indian companies exporting dapagliflozin to Philippines, ranked by total trade value. The listed exporters are: INVENTIA HEALTHCARE LIMITED, EXEMED PHARMACEUTICALS, MICRO LABS LIMITED, BAROQUE PHARMACEUTICALS PVT LTD, Sasha Life Healthcare, DEEPA INTERNATIONAL, STALLION LABORATORIES PVT LTD, SAIN MEDICAMENTS PRIVATE LIMITED, MITOGENE TECHNOLOGIES PRIVATE LIMITED. INVENTIA HEALTHCARE LIMITED is the dominant supplier with 11 shipments worth $822.4K USD, giving it a 35% market share. The top 3 suppliers together account for 87% of the total trade value on this route.
Top 10 Dapagliflozin Importers in Philippines
Showing top 10 of 16 known buyers in Philippines receiving Dapagliflozin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dapagliflozin in Philippines include UNILAB, INC., BROWN AND BURK PHILIPPINES INC, AMB HK ENTERPRISES INC, AMB HK ENTERPRISE INC, AMB HK ENTERPRISES INC.,, among 16 total buyers. The largest importer is UNILAB, INC., accounting for $581.8K USD across 4 shipments — representing 25% of all dapagliflozin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UNILAB, INC. | 4 | $581.8K | 24.5% |
| 2 | BROWN AND BURK PHILIPPINES INC | 11 | $488.5K | 20.6% |
| 3 | AMB HK ENTERPRISES INC | 3 | $404.7K | 17.0% |
| 4 | AMB HK ENTERPRISE INC | 2 | $232.6K | 9.8% |
| 5 | AMB HK ENTERPRISES INC., | 3 | $194.4K | 8.2% |
| 6 | HOVID INC | 3 | $139.7K | 5.9% |
| 7 | TO THE ORDER | 2 | $129.6K | 5.5% |
| 8 | HEALOL PHARMA CORPORATION | 2 | $50.8K | 2.1% |
| 9 | M S 4LIFE HEALTHCARE INC | 2 | $36.1K | 1.5% |
| 10 | 4LIFE HEALTHCARE INC | 1 | $31.0K | 1.3% |
Showing top 10 of 16 Dapagliflozin importers in Philippines on this route.
Top 10 Dapagliflozin Formulations Imported by Philippines
Showing top 10 of 38 product formulations shipped on the India to Philippines Dapagliflozin route, ranked by trade value
Philippines imports a wide range of dapagliflozin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICAL PRODUCT CATANIA MAX DAPAGLIFLOZIN AS PROPANEDIOL MONOHYDRATE METFORMIN HYDROCHLORIDE IN EXTENDED REL — accounts for $224.3K USD across 1 shipments. There are 38 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL PRODUCT CATANIA MAX DAPAGLIFLOZIN AS PROPANEDIOL MONOHYDRATE METFORMIN HYDROCHLORIDE IN EXTENDED REL | 1 | $224.3K | 9.4% |
| 2 | CATANIA DAPAGLIFLOZIN (AS PROPANEDIOL MONOHYDRATE) 10MG FILM-COATED TABLET | 3 | $194.4K | 8.2% |
| 3 | GLYHART (DAPAGLIFLOZIN TABLETS 10 MG) (ACT.QTY:46328 X4X7) | 1 | $185.3K | 7.8% |
| 4 | CATANIA MAX DAPAGLIFLOZIN (AS PROPANEDIOLMONOHYDRATE) + METFORMIN HYDROCHLORIDE (IN EXTENDED-RELEASE FORM) 10MG/1G FILM- | 1 | $181.3K | 7.6% |
| 5 | DAJIO-10 (DAPAGLIFLOZIN TABLETS 10MG) (3X10s) - TAX INVOICE NO: 701209681 DT: 06.01.2025 | 1 | $174.4K | 7.3% |
| 6 | GLYHART (DAPAGLIFLOZIN TABLETS 10 MG) (ACT.QTY:41314X4X7) | 1 | $165.3K | 7.0% |
| 7 | TAX INVOICE NO:1520240894 DATE:31.03.2025 HS CODE 30049099 HARMLESS PHARMACEUTICAL GLYHART (DAPAGLIFLOZIN TABLETS 10 MG) | 1 | $155.3K | 6.5% |
| 8 | PHARMACEUTICAL PRODUCT CATANIA PLUS DAPAGLIFLOZIN AS PROPANEDIOL MONOHYDRATE METFORMIN HYDROCHLORIDE IN EXTENDED RE | 1 | $93.0K | 3.9% |
| 9 | CATANIA MAX DAPAGLIFLOZIN (AS PROPANEDIOL MONOHYDRATE) + METFORMIN HYDROCHLORIDE(IN EXTENDED-RELEASE FORM) 10 | 1 | $87.5K | 3.7% |
| 10 | TAX INVOICE NO:1520240742 DT:05.02.2025HS CODE 30049099 HARMLESS PHARMACEUTICALGLYHART (DAPAGLIFLOZIN TABLETS 10 MG)** | 1 | $75.9K | 3.2% |
Showing top 10 of 38 Dapagliflozin formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 8 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's dapagliflozin exports to Philippines are driven primarily by a handful of large-scale manufacturers. INVENTIA HEALTHCARE LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INVENTIA HEALTHCARE LIMITED, EXEMED PHARMACEUTICALS, MICRO LABS LIMITED — together account for 87% of total trade value on this route. The average shipment value of $59.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as catania dapagliflozin (as propanediol monohydrate) 10mg film-coated tablet and glyhart (dapagliflozin tablets 10 mg) (act.qty:46328 x4x7), suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, UNILAB, INC. is the largest importer with 4 shipments worth $581.8K USD — representing 25% of all dapagliflozin imports from India on this route. A total of 16 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.4M
- Avg. Shipment
- $59.4K
- Suppliers
- 9
- Buyers
- 16
- Transit (Sea)
- ~24 days
- Annual Growth
- +26.8%
Related Analysis
Other Dapagliflozin Routes
Unlock the Full India to Philippines Dapagliflozin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 40 shipments on this route.
Frequently Asked Questions — India to Philippines Dapagliflozin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dapagliflozin to Philippines?
The leading Indian exporters of Dapagliflozin to Philippines are INVENTIA HEALTHCARE LIMITED, EXEMED PHARMACEUTICALS, MICRO LABS LIMITED. INVENTIA HEALTHCARE LIMITED holds the largest market share at approximately 35% of total trade value on this route.
Q What is the total value of Dapagliflozin exports from India to Philippines?
India exports Dapagliflozin to Philippines worth approximately $2.4M USD across 40 recorded shipments. The average value per shipment is $59.4K USD.
Q Which ports does India use to ship Dapagliflozin to Philippines?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 8 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Philippines for Dapagliflozin?
The average transit time for Dapagliflozin shipments from India to Philippines is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Philippines Dapagliflozin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.8% with demand growth tracking at 24.4%. The route is ranked #8 among India's top Dapagliflozin export destinations globally.
Q How many suppliers are active on the India to Philippines Dapagliflozin route?
There are currently 9 active Indian suppliers exporting Dapagliflozin to Philippines. The market is moderately concentrated with INVENTIA HEALTHCARE LIMITED accounting for 35% of total shipment value.
Q Who are the main importers of Dapagliflozin from India in Philippines?
The leading importers of Indian Dapagliflozin in Philippines include UNILAB, INC., BROWN AND BURK PHILIPPINES INC, AMB HK ENTERPRISES INC, AMB HK ENTERPRISE INC, AMB HK ENTERPRISES INC.,. UNILAB, INC. is the largest buyer with 4 shipments worth $581.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Dapagliflozin.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 16 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 40 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
40 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists